GREENBROOK TMS INC (GBNH)
CA3937043097 - Common Stock
We assign a fundamental rating of 2 out of 10 to GBNH. GBNH was compared to 117 industry peers in the Health Care Providers & Services industry. GBNH may be in some trouble as it scores bad on both profitability and health. GBNH is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
GBNH had negative earnings in the past year.
In the past year GBNH has reported a negative cash flow from operations.
In the past 5 years GBNH always reported negative net income.
In the past 5 years GBNH always reported negative operating cash flow.
1.2 Ratios
GBNH's Return On Assets of -78.11% is on the low side compared to the rest of the industry. GBNH is outperformed by 88.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -78.11% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-46.27%
ROA(5y)-38.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 44.95%, GBNH is doing good in the industry, outperforming 75.42% of the companies in the same industry.
In the last couple of years the Gross Margin of GBNH has grown nicely.
GBNH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.95% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y7.57%
2. Health
2.1 Basic Checks
GBNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GBNH has been increased compared to 1 year ago.
The number of shares outstanding for GBNH has been increased compared to 5 years ago.
GBNH has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -3.13, we must say that GBNH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.13, GBNH is doing worse than 82.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.13 |
ROIC/WACCN/A
WACC8.23%
2.3 Liquidity
A Current Ratio of 0.52 indicates that GBNH may have some problems paying its short term obligations.
GBNH has a worse Current ratio (0.52) than 91.53% of its industry peers.
A Quick Ratio of 0.52 indicates that GBNH may have some problems paying its short term obligations.
GBNH has a worse Quick ratio (0.52) than 86.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
GBNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.69%.
GBNH shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.06%.
Measured over the past years, GBNH shows a very strong growth in Revenue. The Revenue has been growing by 38.05% on average per year.
EPS 1Y (TTM)-49.69%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q26.83%
Revenue 1Y (TTM)47.06%
Revenue growth 3Y24.64%
Revenue growth 5Y38.05%
Revenue growth Q2Q29.13%
3.2 Future
The Earnings Per Share is expected to grow by 35.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, GBNH will show a quite strong growth in Revenue. The Revenue will grow by 13.01% on average per year.
EPS Next Y58.2%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.64%
Revenue Next 2Y13.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
GBNH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GBNH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as GBNH's earnings are expected to grow with 35.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.18%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for GBNH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GREENBROOK TMS INC
NASDAQ:GBNH (2/23/2024, 7:00:01 PM)
After market: 0.1153 -0.01 (-4.71%)0.121
-0.08 (-40.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.18M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -78.11% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.95% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.52 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-49.69%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y58.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)47.06%
Revenue growth 3Y24.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y